The power of underpower
This article was originally published in Scrip
Executive Summary
The news that specialty group Shire Pharmaceuticals is to conduct underpowered Phase IV studies comparing its ADHD drug Vyvanse with the market leader, J&J’s Concerta, is very welcome.